Straumann速 Dental Implant System
More than an implant.
A sense of trust.
45X.002.indd 1
20.02.14 14:36
More than an implant.
A sense of trust.
When patients need a tooth replacement, you want to provide them with the best possible solution and exceed their expectations. The Straumann® Dental Implant System is designed to support you in this process by improving treatment outcomes built on a history of pioneering implant dentistry and reliable scientific evidence.
Trust based on 60 years of quality and innovations 1954
1997
Founding of the research institute Institut Dr. Ing. R. Straumann AG
SLA® – Pioneering surface technology cuts healing time in half 1
1974 First dental implants including the world’s first one-stage implant are developed at Straumann
2
45X.002.indd 2
20.02.14 14:36
NUMBER OF STUDY PUBLICATIONS AND PEER-REVIEWED PUBLICATIONS ON STRAUMANN PRODUCTS 31
2012
16
130
39
2011
24
28
2010
130
54
2009
37
2008
37
130
33
120
20
100 50
0 Preclinical
100 Clinical
150
200
Peer-reviewed
2009 Roxolid® – The new “DNA” of implant materials. Exclusively designed for the use in dental implantology
2005 SLActive® surface technology reduces reported implant loss rate to 0.6 %2
2013 Introducing the full Roxolid® portfolio – setting new standards by reducing invasiveness
3
45X.002.indd 3
20.02.14 14:36
More than flexible.
A new kind of esthetics.
For a natural look and feel. The Straumann® Bone Level Implant Line provides great flexibility to deliver an esthetically pleasing solution to patients.
Optimized crestal bone preser vation with Bone Control Design™ Pleasing esthetic results with Consistent Emergence Profiles™ ѹѹ Optimizes and simplifies soft tissue management ѹѹ Eases the fabrication of temporary and final restorations
ѹѹ Respects the biological distance/width ѹѹ Optimal position of smooth and rough surface interface ѹѹ Microgap control ѹѹ Biomechanical implant design ѹѹ Implant surface osteoconductivity
Simplified handling with the CrossFit® connection ѹѹ Makes handling easier and provides confidence about component positioning ѹѹ Ensures precision against rotation ѹѹ Offers restorative flexibility and long-term mechanical stability
Well-proven new materials ѹѹ Titanium Grade 4 ѹѹ Roxolid®: A titanium-zirconium alloy stronger than titanium6,7 and specifically designed for the use in dental implantology
4
45X.002.indd 4
20.02.14 14:36
More than efficient.
A simple procedure.
The Straumann® Soft Tissue Level Implants are designed to simplify treatment. The one-stage surgical procedure will allow you to save time and increase efficiency in your practice. Cover a wide range of indications with 3 different implant lines – Standard, Standard Plus and Tapered Effect.
Flexible and reliable with the synOcta® connection
Innovative surfaces ѹѹ SLA®, the reliable and scientifically well-documented surface, with predictable long-term clinical data3,4 ѹѹ SLActive®, the next generation in implant surface technology reduces the critical healing period down to 3 – 4 weeks5 and minimizes the potential for early implant failure
ѹѹ The internal octagon: Secure and flexible (re)positioning of individual abutments in the implant ѹѹ Morse taper connection: Uniform load distribution and reliable, stable implant-to-abutment joints prevent rotation
Take advantage of the easy accessibility to the implant by working at soft tissue level ѹѹ Lean prosthetic portfolio supported by the implant design ѹѹ Simple impression taking and abutment placement thanks to the connection at soft tissue level
5
45X.002.indd 5
20.02.14 14:36
More than a surface.
A new level of confidence.
SLActive® – simply better. Our hydrophilic SLActive® surface is designed to deliver: ѹѹ Higher security and faster osseointegration for every indication14-20 ѹѹ Reduced healing times from 6 – 8 weeks down to 3 – 4 weeks14-19 ѹѹ Increased treatment predictability in critical protocols20
HIGHER PREDICTABILITY 5,21 New bone on the implant surface
Most implant failures occur in the critical early period between weeks 2 and 422. Although similar healing patterns were observed for both SLA® and SLActive® Implants, bone-to-implant contact (BIC) was greater after 2 weeks and significantly greater after 4 weeks for SLActive® (p < 0.05).23
70 % 60 % 50 % 40 % 30 % 20 % 10 % 0 % 0
1
2
3
4
5
6
Healing periods in weeks SLActive®
SLA®
PROMOTION OF BONE REGENERATION IN DEHISCENCE-TYPE DEFECTS24,25 Critical situations such as dehiscence defects are always a challenge and put success at risk. With SLActive®, new bone volume and BIC are significantly higher. Preclinical studies in dogs showed that SLActive® Implants promote the production of more mature bone than SLA® Implants would. This outcome suggests that SLActive® may have a high potential for supporting osseointegration in dehicence-type defects.
SLActive® 80 % BIC after 12 weeks
SLA® 5 % BIC after 12 weeks
6
45X.002.indd 6
20.02.14 14:36
More than solid.
Less invasive.
1000 Tensile strength (MPa)
Roxolid® is a groundbreaking material specifically designed for the use in dental implantology. The titanium-zirconium alloy is stronger than pure titanium6,7 and has excellent osseointegration properties8-10. This combination of properties is unique in the market – there is no other metallic alloy which unifies high mechanical strength and osteoconductivity.
+ ~75 %
800
+ ~20 %
600 400 ASTM TiGr43
Straumann® cold-worked TiGr4 4
Straumann® Roxolid®4
MORE TREATMENT OPTIONS WITH SMALLER IMPLANTS Thanks to their outstanding biological and mechanical properties, Roxolid® Implants offer more treatment options than conventional small titanium implants.
Case treated with Straumann® Standard Plus 4 mm Implants
PRESERVE BONE AND REDUCE INVASIVE GRAFTING PROCEDURES11,12 Roxolid® might allow you to choose smaller implants. These implants have the potential to preserve peri-implant structures and avoid invasive bone grafting procedures.
COULD A BONE AUGMENTATION PROCEDURE BE AVOIDED BY USING ROXOLID® 3.3 MM IMPLANTS?11 60 % 50 % 40 %
54 %
30 % 20 %
25 %
10 %
21 %
0 % YES
NO
Augmentation had to be performed despite 3.3 mm implant
INCREASE PATIENT ACCEPTANCE WITH LESS INVASIVE PROCEDURES13 Treating patients without invasive grafting procedures offers your patients a less traumatic, faster treatment at lower cost. These advantages have the potential to make dental implant treatments appealing to more patients.
7
45X.002.indd 7
20.02.14 14:36
More than many possibilities.
Just Freedom.
MORE OPTIONS. INCREASED PERFORMANCE. ROXOLID® SLA®
MORE FACTS. MORE EXPERIENCE. TITANIUM SLA®
Long-term reliability supported by scientific evidence ѹѹ Various studies show a high success rate with SLA® after 10-year follow up3,4 ѹѹ Over 100 peer-reviewed papers published Unique access to two implant approaches: the original Soft Tissue Level Implant Line and the innovative Bone Level Implant Line ѹѹ Esthetic cases can be treated with Bone Level Implants ѹѹ Efficient straight forward procedure with the original Soft Tissue Level Implants ѹѹ One surgical kit for all implant lines
More treatment options with smaller implants ѹѹ More treatment options thanks to smaller implants with higher material strength6,7 ѹѹ Confidence thanks to the excellent mechanical and biological performance of Roxolid® Preserve bone and reduce invasive grafting procedures11,12 ѹѹ Wide usage of small implants protects vital structures and vascularization ѹѹ Reduced implant size can eliminate the need of GBR procedures for specific cases Increase patient acceptance with less invasive procedures13 ѹѹ Reduced invasiveness might increase acceptance of implant treatment as connected with less discomfort, cost and time ѹѹ Increase your business performance
Support by Straumann quality and services ѹѹ Highest precision abutment-implant fit with original parts ѹѹ Extensive education program offering new possibilities and generating professional network ѹѹ Comprehensive service program including life-time warranty on implants
8
45X.002.indd 8
20.02.14 14:36
MORE SECURITY. MORE PEACE OF MIND. ROXOLID® SLActive®
Higher security in all indications14-20 ѹѹ Straumann’s best material-surface combination ѹѹ Improved treatment predictability ѹѹ Minimize the risk of early implant failures Predictable treatment success even in challenging cases9,20,25 ѹѹ Promotion of bone regeneration in dehiscencetype defects24,25 ѹѹ Preclinical study indicating increased bone quality in an osteoporotic model9 ѹѹ High success rates with immediate loading protocols20 Practice differentiator offering new treatment possibilities ѹѹ More patient friendly treatment options ѹѹ Vertical space is no longer a limitation with the Standard Plus Short Implant ѹѹ Predictable immediate loading protocols reducing treatment time20
9
45X.002.indd 9
20.02.14 14:36
More than a restoration.
A perfect fit for all needs.
For both Soft Tissue Level and Bone Level Implants, Straumann offers a broad range of standard and CADCAM abutments in leading materials and a full application range – designed to create the optimal restorative result for virtually any case.
For ease of use, you need only one restorative kit for both Soft Tissue Level and Bone Level Implants. This single kit is easy to master, simple to handle and allows for convenient component management.
SCREW-RETAINED RESTORATIONS*/** Standard solutions
Customized solutions
Gold Abutment
Multibase
synOcta® 1.5
CEMENT-RETAINED*/** Standard solutions
Variobase™
Screw-retained Bridges
Ceramic Customized Abutment
HYBRID RESTORATIONS** Customized solutions
Cementable
Solid
Customized Abutments
LOCATOR®
Bar
SFI-Anchor®
Screw-retained Bars
* certain solutions can also be used for screw-retained or cement-retained restorations ** only a selection of solution examples is displayed
10
45X.002.indd 10
20.02.14 14:36
More than just a transfer piece.
Easy handling.
The Straumann® Roxolid® Implants are delivered with the new Loxim™ Transfer Piece, which is connected to the implant with a snap-in mounting.
FEATURES
BENEFITS
Snap-in mounting …
… for easy handling without counter-maneuvering
Blue color …
… for high visibility
Compact dimensions …
… for easy access
Height markings …
… for correct implant placement
Pre-determined breaking point …
… for protecting the inner implant configuration
11
45X.002.indd 11
20.02.14 14:36
More than a tooth-colored implant.
Unique natural esthetics.
%P 100 RO
% PRO 100
-TESTED • OF
Some patients have a thin gingiva biotype, and therefore require a different treatment approach, while other patients express their explicit wish for a metal-free alternative. With the new Straumann® PURE Ceramic Implant we offer an esthetic solution that allows you to treat patients with these specific needs and demands.
-TESTED • OF
THIS SOLUTION IS BASED ON DECADES OF STRAUMANN’S EXPERIENCE AND KNOW-HOW IN IMPLANT DENTISTRY ѹѹ ѹѹ ѹѹ ѹѹ
Revolutionary healing patterns comparable to titanium implants thanks to the ZLATM surface26,27 Reliable implant strength as every implant is proof-tested before release High end esthetic solution thanks to the ivory-colored material Expand your patient pool with an innovative metal-free solution
12
45X.002.indd 12
20.02.14 14:36
More than convenience.
A simple workflow.
TR
ENT S TM A E
SA M E F O R
AL
L
The Straumann® Surgical Kit and Prosthetic Kit can be used for all implant lines of the Straumann® Dental Implant System.
• SURGICAL KIT • PROSTHETIC KIT • PROCEDURE
13
45X.002.indd 13
20.02.14 14:36
14
45X.002.indd 14
20.02.14 14:36
REFERENCES
1 Scacchi M. et al., The development of the ITI DENTAL IMPLANT SYSTEM. Part 2: 1998-2000: Steps into the next millennium. Clin Oral Implants Res 2000; 11: 22-32 2 Based upon global Straumann® SLActive® complaint statistics 2005-2006 3 Fischer K., Stenberg T. al ‘Prospective 10-year Cohort Study Based on a Randomized Controlled Trial (RCT) on Implant-Supported Full-Arch Maxillary Prostheses. Part 1: Sandblasted and Acid-Etched Implants and Mucosal Tissue.’ Clin Implant Dent Relat Research. 2012 Dec;14(6):808-15 4 Fischer K, Stenberg T. ‘Prospective 10-year cohort study based on a randomized, controlled clinical trial (RCT) on implant-supported full-arch maxillary prostheses. Part II: Prosthetic outcomes and maintenance.’ Clin Implant Dent Relat Research.. 2013 Aug;15(4):498-508 5 Oates TW. et al. ‘Enhanced implant stability with a chemically modified SLA® surface: a randomized pilot study.’ Int. J. Oral Maxillofac. Implants. 2007;22(5):755–760. 6 Norm ASTM F67 (states min. tensile strength of annealed titanium). 7 Data on file for Straumann cold-worked titanium and Roxolid® Implants. 8 Gottlow J et al. ‘Evaluation of a new titanium-zirconium dental implant: a biomechanical and histological comparative study in the mini pig.’ Journal of Clinical Implant Dentistry and Related Research 2012; 14: 538-545 9 Wen B et al. ‘The osseointegration behavior of titanium-zirconium implants in ovariectomized rabbits.’ Clin Oral Implants Res. 2013 Feb 21. 10 Barter S et al. ‘A pilot study to evaluate the success and survival rate of titanium-zirconium implants in partially edentulous patients: results after 24 months of follow-up.’ Clin Oral Implants Res. 2012 Jul;23(7):873-81 11 Freiberger P, Al-Nawas B. ‘Non-interventional Study on Success and Survival of TiZr Implants.’ EAO 2012 Copenhagen; 305 Posters – Implant Therapy Outcomes, Surgical Aspects 12 Benic GI et al. ‘Titanium-zirconium narrow-diameter versus titanium regular-diameter implants for anterior and premolar single crowns: 1-year results of a randomized controlled clinical study.’ Journal of Clinical Periodontology 2013; [Epub ahead of print] 13 If a GBR procedure can be avoided 14 Buser D. et al. ‚Enhanced bone apposition to a chemically modified SLA titanium surface.’ J. Dent. Res. 2004 Jul;83(7):529–33. 15 Schwarz F. et al. ‘Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA® titanium implants: Preliminary results of a pilot study in dogs.’ Clin. Oral Impl. Res. 2007;11(4):481–488. 16 Schwarz F, et al. ‘Histological and immunohistochemical analysis of initial and early subepithelial connective tissue attachment at chemically modified and conventional SLA® titanium implants. A pilot study in dogs.’ Clin. Oral Impl. Res. 2007;11(3):245–455. 17 Schwarz F, et al. ‘Effects of surface hydrophilicity and microtopography on early stages of soft and hard tissue integration at non-submerged titanium implants: An immunohistochemical study in dogs.’ J. Periodontol. 2007;78(11):2171–2184. 18 Schwarz F,et al. ‘Bone regeneration in dehiscence-type defects at chemically modified (SLActive) and conventional SLA titanium: A pilot study in dogs.’ J. Clin. Periodontol. 2007;34(1):78–86. 19 Zöllner et al. ’Immediate and early non-occlusal loading of Straumann implants with a chemically modified surface (SLActive®) in the posterior mandible and maxilla: interim results from a prospective multicentre randomized-controlled study.’ Clinical Oral Implants Research, 19(5), 442-450,2008. 20 Nicolau P. et al. ‘Immediate and early loading of chronically modified implants in posterior jaws: 3-year results from a prospective randomized study‘ Clin Implant Dent Relat Res. 2013 Aug;15(4):600-612 21 Bornstein mm et al. ‘Early loading at 21 days of non-submerged titanium implants with a chemically modified sandblasted and acid-etched surface: 3-year results of a prospective study in the posterior mandible’. J. Periodontol. 2010 Jun;81 (6):809–18. 22 Raghavendra S, et al. Int. J. Oral Maxillofac. Implants. 2005 May–Jun;20(3):425–31. 23 Lang, NP., et al. ‘Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans.’ Clin Oral Implants.Res 22.4 (2011): 349–56 24 Schwarz, F., et al., ‘Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA titanium implants: a pilot study in dogs’ J Clin.Periodontol. 34.1 (2007): 78–86 25 Schwarz, F., et al., ‘Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA titanium implants: an immunohistochemical study in dogs.’ J Clin.Periodontol. 35.1 (2008): 64–75. 26 Gahlert M et al. ‚ In vivo performance of zirconia and titanium implants: a histomorphometric study in mini pig maxillae.’ Clin Oral Implants Res. 2012 Mar;23(3):2816 27 Bormann KH et al. ‚ Biomechanical evaluation of a microstructured zirconia implant by a removal torque comparison with a standard Ti-SLA implant.’ Clin Oral Implants Res. 2012 Oct; 23(10):1210-6
15
45X.002.indd 15
20.02.14 14:36
© Institut Straumann AG, 2014. All rights reserved. Straumann® and/or other trademarks and logos from Straumann® mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates. All rights reserved.
45X.002.indd 16
Straumann products are CE marked 01/14 452.002/A/000
International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01 www.straumann.com
20.02.14 14:36